Scientific documentation of the Iranian radiopharmaceutical development program in the horizon 2025 in comparison to other regional competitors: A scientometric study

Document Type : Systematic Review/Meta-analysis


1 Social Determinants of Health Research Center, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

2 Health Foresight and Innovation Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran


Introduction: Production and applicationofradiopharmaceuticals is one of the priorities in the comprehensive health map of Iran. The present study examines the scientific documentation of the Iranian radiopharmaceutical development program in the horizon 2025 in comparison to other regional competitors.
Methods: The present study is a descriptive review performed by the scientometric method. The sources of data collection are studies conducted in the Web of Science database (Clarivate Analytics) from 1992 to 2021. Excel software was used to collect data and data analysis.
Results: Among the countries in the horizon 2025, the highest rank of science production belongs to Iran and Turkey, each with 2.6%. The highest level of citation belongs to Turkey with 1.8% followed by Iran with 1.7%. Most of the radiopharmaceutical scientific productions and citations in Iran are recorded in 2020 (16.6% and 10.2%, respectively). The highest share of research area belongs to nuclear science technology with 37.1%. Iran has the most international cooperation with the United States (3.5%) and most citations from the scientific partnership with China (12.3%). Nuclear Science Research Center has the most share of science production and citations (22.1% and 7.1%, respectively). AR Jalilian is the top Iranian researcher with 11.5 percent of the total Iranian output in the radiopharmaceutical field.
Conclusion: Although Iran ranks first in the production of science and second in citation recorded among competing countries, there is a need for continuous comprehensive nuclear science research and development plan for quantitative and qualitative advancement of this field. In addition, the Iranian researchers require having more interaction, scientific communication and cooperation with academic center in countries with advanced technology in nuclear and health sciences, especially East Asian countries.


Main Subjects

  1. Niksirat F, Monfared AS, Deevband MR, Amiri M, Gholami A. Estimating the population dose from nuclear medicine examinations towards establishing diagnostic reference levels. Indian J Nucl Med. 2016 Jan-Mar;31(1):31-5.
  2. Lorestani S, Yahyazadehfar M, Miremadi T, Alizadeh Sani M. Identifying the innovation motor of radiopharmaceutical technology innovation system in Iran. J Technol Dev Manag. 2018;6(2):71-100.
  3. Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M. Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran. Semin Nucl Med. 2016 Jul;46(4):340-58.
  4. Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Radiopharmaceutical therapy in cancer: clinical advances and hallenges. Nat Rev Drug Discov. 2020 Sep;19(9):589-608.
  5. 5 van der Pol J, Vöö S, Bucerius J, Mottaghy FM. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review. Eur J Nucl Med Mol Imaging. 2017 Jul 1;44(7):1234-43.
  6. Dowlatabadi Bazaz R, Beiki D, Khalaj A. Radiopharmaceutical regulation worldwide - The resemblances and the differences. Iran J Nucl Med. 2005;13(1):1-13.
  7. Jalilian AR, Beiki D. The present status of radiopharmaceuticals in the country. Iran J Pharm Res. 2016 Summer;15(3):257-259.
  8. Paez, D, Becic, T, Bhonsle U, Jalilian A, Nuñez-Miller R, Osso J. Current status of nuclear medicine practice in the Middle East. Semin Nucl Med. 2016;46:265 272.
  9. Cheshmyazdan M, Bamir M, Dehnavieh R, Masoud A, Setayesh AH, Karamoozian A. Comparing scientific production of prioritized health areas of Iran's comprehensive scientific map with outlook horizon 1404 countries, a scientometric study: brief report. Tehran Univ Med J. 2020;78(7):466-472.
  10. Ministry of Health and Medical Education. Comprehensive health plan. Available from:
  11. Dehnavieh R, Haghdoost A, Noori Hekmat S, Bamir M, Masoud A, Poursheikhali A, Chashmyazdan R. Evaluation of the trend of qualitative and quantitative growth of scientific products in prioritized health fields during 2010-2017 based on scientometric indicactors. Iranian J Epidemiol 2019;14:93-102
  12. Cheshmyazdan M, Dehnavieh R, Bamir M, Poursheikhali A, Noori HS. The survey on the amount of scientific productions in the field of obstetrics and gynecology before and after the health reform plan. Tehran Univ Med J. 2019;77(8):498-504.